A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes

BACKGROUND: Dys-megakaryopoiesis is defined as ≥10 % of dysplastic megakaryocytes in bone marrow smears by the World Health Organization. However, concordance rates for dysplastic megakaryocytes between different observers is low and, consequently, evaluation of dysmegakaryopoiesis is also often dis...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Exp Hematol Oncol
Auteurs principaux: Feng, Gege, Gale, Robert Peter, Cui, Wen, Cai, Wenyu, Huang, Gang, Xu, Zefeng, Qin, Tiejun, Zhang, Yue, Li, Bing, Fang, Liwei, Zhang, Hongli, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Wang, Jingya, Cui, Yajuan, Xiao, Zhijian
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4848808/
https://ncbi.nlm.nih.gov/pubmed/27127725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-016-0041-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires